| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Arsenic | 55 | 2025 | 266 | 10.630 |
Why?
|
| Environmental Exposure | 34 | 2025 | 340 | 4.920 |
Why?
|
| Water Pollutants, Chemical | 23 | 2022 | 139 | 3.720 |
Why?
|
| Bangladesh | 56 | 2025 | 332 | 2.910 |
Why?
|
| Arsenic Poisoning | 15 | 2019 | 103 | 2.870 |
Why?
|
| Environmental Pollutants | 7 | 2022 | 54 | 2.180 |
Why?
|
| Metals | 6 | 2025 | 100 | 2.170 |
Why?
|
| Oryza | 5 | 2021 | 42 | 1.700 |
Why?
|
| DNA Methylation | 10 | 2025 | 677 | 1.650 |
Why?
|
| Drinking Water | 10 | 2022 | 68 | 1.600 |
Why?
|
| Maternal Exposure | 6 | 2021 | 60 | 1.590 |
Why?
|
| Diet | 8 | 2019 | 448 | 1.440 |
Why?
|
| Skin Diseases | 13 | 2019 | 175 | 1.440 |
Why?
|
| Telomere | 5 | 2025 | 119 | 1.420 |
Why?
|
| Female | 97 | 2025 | 47893 | 1.200 |
Why?
|
| Polymorphism, Single Nucleotide | 21 | 2021 | 2449 | 1.200 |
Why?
|
| Middle Aged | 79 | 2025 | 27043 | 1.140 |
Why?
|
| Prenatal Exposure Delayed Effects | 2 | 2021 | 168 | 1.110 |
Why?
|
| Cohort Studies | 24 | 2023 | 2978 | 1.110 |
Why?
|
| Gene-Environment Interaction | 5 | 2025 | 118 | 1.060 |
Why?
|
| Blood Pressure | 8 | 2020 | 907 | 1.060 |
Why?
|
| Water Supply | 12 | 2022 | 62 | 1.060 |
Why?
|
| Pregnancy Outcome | 2 | 2020 | 265 | 1.060 |
Why?
|
| Adult | 77 | 2025 | 27536 | 1.050 |
Why?
|
| Male | 84 | 2025 | 43926 | 1.030 |
Why?
|
| Cacodylic Acid | 4 | 2021 | 22 | 1.030 |
Why?
|
| Humans | 121 | 2025 | 92333 | 1.020 |
Why?
|
| Nutrition Surveys | 7 | 2022 | 114 | 1.010 |
Why?
|
| Vital Capacity | 4 | 2021 | 69 | 0.990 |
Why?
|
| Lung | 4 | 2021 | 1337 | 0.980 |
Why?
|
| Epigenesis, Genetic | 5 | 2025 | 538 | 0.960 |
Why?
|
| Groundwater | 2 | 2022 | 14 | 0.930 |
Why?
|
| Metals, Heavy | 3 | 2019 | 16 | 0.910 |
Why?
|
| Environmental Monitoring | 7 | 2024 | 82 | 0.900 |
Why?
|
| Asthma | 2 | 2021 | 1003 | 0.820 |
Why?
|
| Allostasis | 1 | 2023 | 2 | 0.810 |
Why?
|
| Genetic Predisposition to Disease | 15 | 2021 | 2396 | 0.810 |
Why?
|
| Cardiovascular Diseases | 9 | 2021 | 741 | 0.800 |
Why?
|
| Child | 13 | 2025 | 7309 | 0.790 |
Why?
|
| Skin Neoplasms | 6 | 2025 | 606 | 0.770 |
Why?
|
| Aged | 48 | 2025 | 19951 | 0.770 |
Why?
|
| Occupational Exposure | 3 | 2018 | 88 | 0.770 |
Why?
|
| Hypertension | 5 | 2019 | 763 | 0.760 |
Why?
|
| Forced Expiratory Volume | 2 | 2021 | 128 | 0.760 |
Why?
|
| Selenium | 3 | 2019 | 46 | 0.710 |
Why?
|
| Pesticides | 4 | 2020 | 29 | 0.700 |
Why?
|
| Prospective Studies | 25 | 2020 | 4470 | 0.690 |
Why?
|
| Gravidity | 1 | 2020 | 7 | 0.690 |
Why?
|
| Adolescent | 33 | 2024 | 9494 | 0.690 |
Why?
|
| Metabolic Syndrome | 2 | 2018 | 127 | 0.670 |
Why?
|
| Longitudinal Studies | 20 | 2025 | 1117 | 0.670 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 6 | 2017 | 696 | 0.660 |
Why?
|
| Smoking | 8 | 2019 | 640 | 0.650 |
Why?
|
| Genome-Wide Association Study | 14 | 2021 | 1724 | 0.620 |
Why?
|
| Young Adult | 32 | 2023 | 6629 | 0.620 |
Why?
|
| Cardiotoxins | 1 | 2018 | 3 | 0.620 |
Why?
|
| Manganese | 1 | 2019 | 56 | 0.610 |
Why?
|
| Residence Characteristics | 1 | 2020 | 203 | 0.610 |
Why?
|
| Food | 3 | 2015 | 93 | 0.600 |
Why?
|
| Food Contamination | 5 | 2019 | 34 | 0.600 |
Why?
|
| Risk Factors | 21 | 2023 | 5705 | 0.590 |
Why?
|
| Pregnancy | 8 | 2022 | 3112 | 0.580 |
Why?
|
| Cross-Sectional Studies | 10 | 2021 | 1774 | 0.580 |
Why?
|
| Diabetes Mellitus, Type 2 | 4 | 2024 | 1210 | 0.570 |
Why?
|
| Child Mortality | 1 | 2017 | 6 | 0.560 |
Why?
|
| Potassium Channels, Tandem Pore Domain | 1 | 2017 | 16 | 0.560 |
Why?
|
| Urinalysis | 1 | 2017 | 31 | 0.550 |
Why?
|
| Obesity | 3 | 2021 | 1014 | 0.540 |
Why?
|
| Diet, Gluten-Free | 1 | 2017 | 59 | 0.520 |
Why?
|
| Birth Weight | 3 | 2022 | 149 | 0.510 |
Why?
|
| Arsenicals | 5 | 2019 | 48 | 0.500 |
Why?
|
| Antioxidants | 3 | 2013 | 224 | 0.500 |
Why?
|
| Carcinogens | 1 | 2016 | 112 | 0.490 |
Why?
|
| United States | 15 | 2025 | 7348 | 0.490 |
Why?
|
| Selenomethionine | 2 | 2013 | 11 | 0.480 |
Why?
|
| Proportional Hazards Models | 6 | 2020 | 871 | 0.480 |
Why?
|
| Lung Diseases | 2 | 2016 | 283 | 0.480 |
Why?
|
| Telomere Homeostasis | 3 | 2021 | 30 | 0.470 |
Why?
|
| Triple Negative Breast Neoplasms | 1 | 2017 | 177 | 0.460 |
Why?
|
| Leukocytes | 3 | 2025 | 212 | 0.460 |
Why?
|
| Quantitative Trait Loci | 5 | 2021 | 628 | 0.440 |
Why?
|
| Gene Expression | 2 | 2018 | 1315 | 0.440 |
Why?
|
| Mendelian Randomization Analysis | 3 | 2021 | 48 | 0.440 |
Why?
|
| Transcriptome | 3 | 2025 | 700 | 0.440 |
Why?
|
| Breast Neoplasms | 8 | 2019 | 3054 | 0.430 |
Why?
|
| CpG Islands | 5 | 2019 | 164 | 0.430 |
Why?
|
| Public Health | 3 | 2022 | 145 | 0.430 |
Why?
|
| Water Wells | 4 | 2022 | 18 | 0.420 |
Why?
|
| Digestive System Neoplasms | 1 | 2013 | 22 | 0.420 |
Why?
|
| alpha-Tocopherol | 1 | 2013 | 9 | 0.420 |
Why?
|
| Body Mass Index | 9 | 2021 | 799 | 0.410 |
Why?
|
| Anticarcinogenic Agents | 1 | 2013 | 73 | 0.400 |
Why?
|
| Water Pollution, Chemical | 3 | 2011 | 21 | 0.380 |
Why?
|
| Methyltransferases | 3 | 2019 | 198 | 0.380 |
Why?
|
| Aging | 4 | 2025 | 741 | 0.370 |
Why?
|
| Gene Expression Regulation, Neoplastic | 6 | 2025 | 1310 | 0.370 |
Why?
|
| Genome, Human | 5 | 2019 | 803 | 0.370 |
Why?
|
| Acculturation | 2 | 2023 | 15 | 0.360 |
Why?
|
| Air Pollutants | 2 | 2024 | 97 | 0.350 |
Why?
|
| Child, Preschool | 4 | 2025 | 3805 | 0.330 |
Why?
|
| Vitamin B Complex | 1 | 2010 | 21 | 0.330 |
Why?
|
| Gene Expression Profiling | 6 | 2025 | 1480 | 0.330 |
Why?
|
| Neoplasms | 5 | 2023 | 3124 | 0.330 |
Why?
|
| Phenotype | 9 | 2024 | 2502 | 0.320 |
Why?
|
| Genotype | 8 | 2019 | 1865 | 0.320 |
Why?
|
| Ammonia-Lyases | 2 | 2019 | 6 | 0.310 |
Why?
|
| Glutamate Formimidoyltransferase | 2 | 2019 | 6 | 0.310 |
Why?
|
| Gestational Age | 2 | 2021 | 327 | 0.310 |
Why?
|
| Infant | 3 | 2021 | 3207 | 0.300 |
Why?
|
| Genotyping Techniques | 3 | 2019 | 69 | 0.290 |
Why?
|
| Loss of Heterozygosity | 1 | 2008 | 86 | 0.290 |
Why?
|
| Chicago | 3 | 2021 | 1463 | 0.280 |
Why?
|
| Parity | 2 | 2020 | 97 | 0.280 |
Why?
|
| Gene Amplification | 1 | 2008 | 137 | 0.280 |
Why?
|
| Infant, Newborn | 4 | 2020 | 2506 | 0.280 |
Why?
|
| Gene Expression Regulation | 4 | 2018 | 2007 | 0.280 |
Why?
|
| Mexican Americans | 2 | 2024 | 68 | 0.270 |
Why?
|
| Biomarkers | 6 | 2024 | 1847 | 0.270 |
Why?
|
| Mortality | 3 | 2017 | 150 | 0.260 |
Why?
|
| Chromosome Aberrations | 1 | 2008 | 384 | 0.260 |
Why?
|
| Odds Ratio | 6 | 2019 | 694 | 0.260 |
Why?
|
| Social Class | 1 | 2007 | 138 | 0.260 |
Why?
|
| Prevalence | 7 | 2018 | 1297 | 0.240 |
Why?
|
| Mercury | 1 | 2025 | 12 | 0.230 |
Why?
|
| Nails | 1 | 2025 | 11 | 0.230 |
Why?
|
| Volatile Organic Compounds | 1 | 2024 | 4 | 0.230 |
Why?
|
| Silicones | 1 | 2024 | 21 | 0.230 |
Why?
|
| Wrist | 1 | 2024 | 29 | 0.230 |
Why?
|
| Genetic Research | 1 | 2024 | 18 | 0.230 |
Why?
|
| Prostatic Neoplasms | 1 | 2016 | 1771 | 0.230 |
Why?
|
| Sex Factors | 4 | 2018 | 1094 | 0.220 |
Why?
|
| Metabolome | 1 | 2024 | 61 | 0.220 |
Why?
|
| Lymphocytes | 1 | 2006 | 476 | 0.220 |
Why?
|
| Metabolomics | 1 | 2024 | 95 | 0.220 |
Why?
|
| Sequence Deletion | 1 | 2025 | 211 | 0.220 |
Why?
|
| Life Style | 3 | 2023 | 176 | 0.220 |
Why?
|
| Linear Models | 1 | 2025 | 427 | 0.210 |
Why?
|
| Smoking Cessation | 2 | 2019 | 265 | 0.210 |
Why?
|
| Cadmium | 3 | 2022 | 28 | 0.210 |
Why?
|
| Sleep Wake Disorders | 1 | 2024 | 121 | 0.210 |
Why?
|
| Blood Glucose | 2 | 2024 | 855 | 0.210 |
Why?
|
| Apolipoprotein E4 | 1 | 2023 | 27 | 0.210 |
Why?
|
| Bayes Theorem | 1 | 2025 | 390 | 0.200 |
Why?
|
| Genetic Variation | 3 | 2018 | 1392 | 0.200 |
Why?
|
| Multifunctional Enzymes | 2 | 2019 | 6 | 0.200 |
Why?
|
| Socioeconomic Factors | 2 | 2018 | 609 | 0.190 |
Why?
|
| United Kingdom | 1 | 2023 | 173 | 0.190 |
Why?
|
| Precancerous Conditions | 3 | 2010 | 201 | 0.190 |
Why?
|
| Population Health | 1 | 2022 | 33 | 0.190 |
Why?
|
| Air Pollution | 2 | 2023 | 93 | 0.190 |
Why?
|
| Biological Specimen Banks | 1 | 2023 | 70 | 0.190 |
Why?
|
| Molybdenum | 1 | 2022 | 12 | 0.190 |
Why?
|
| Thinness | 2 | 2014 | 46 | 0.190 |
Why?
|
| Respiration Disorders | 2 | 2013 | 40 | 0.180 |
Why?
|
| Copper | 1 | 2022 | 78 | 0.180 |
Why?
|
| Blood Cells | 1 | 2021 | 33 | 0.180 |
Why?
|
| Databases, Genetic | 3 | 2019 | 274 | 0.180 |
Why?
|
| Telomere Shortening | 1 | 2021 | 25 | 0.180 |
Why?
|
| Regression Analysis | 4 | 2017 | 594 | 0.180 |
Why?
|
| Incidence | 5 | 2018 | 1661 | 0.180 |
Why?
|
| Biomarkers, Tumor | 4 | 2018 | 1576 | 0.180 |
Why?
|
| Alpha-Ketoglutarate-Dependent Dioxygenase FTO | 1 | 2021 | 44 | 0.180 |
Why?
|
| Gonadal Steroid Hormones | 2 | 2023 | 50 | 0.170 |
Why?
|
| Sleep | 1 | 2024 | 462 | 0.170 |
Why?
|
| Cognitive Dysfunction | 1 | 2023 | 166 | 0.170 |
Why?
|
| Water Purification | 1 | 2020 | 4 | 0.170 |
Why?
|
| beta-Globins | 1 | 2019 | 2 | 0.170 |
Why?
|
| Blood | 1 | 2019 | 68 | 0.160 |
Why?
|
| Insulin Resistance | 1 | 2022 | 375 | 0.160 |
Why?
|
| Receptor, EphA4 | 1 | 2019 | 5 | 0.160 |
Why?
|
| Case-Control Studies | 6 | 2018 | 1901 | 0.160 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2021 | 317 | 0.160 |
Why?
|
| Whole Genome Sequencing | 1 | 2019 | 103 | 0.160 |
Why?
|
| Genes, Mitochondrial | 1 | 2018 | 10 | 0.150 |
Why?
|
| Receptors, Opioid | 1 | 2019 | 23 | 0.150 |
Why?
|
| Metabolism | 1 | 2018 | 26 | 0.150 |
Why?
|
| Ions | 1 | 2019 | 76 | 0.150 |
Why?
|
| Tobacco Smoking | 1 | 2019 | 30 | 0.150 |
Why?
|
| Genetic Testing | 1 | 2022 | 550 | 0.150 |
Why?
|
| Aged, 80 and over | 6 | 2020 | 6921 | 0.150 |
Why?
|
| Alzheimer Disease | 1 | 2023 | 518 | 0.150 |
Why?
|
| Exercise | 2 | 2021 | 335 | 0.150 |
Why?
|
| Muscle Contraction | 1 | 2019 | 287 | 0.140 |
Why?
|
| DNA, Mitochondrial | 1 | 2018 | 189 | 0.140 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2019 | 242 | 0.140 |
Why?
|
| Waist-Height Ratio | 1 | 2017 | 2 | 0.140 |
Why?
|
| Atlases as Topic | 1 | 2017 | 10 | 0.140 |
Why?
|
| Abortion, Therapeutic | 1 | 2017 | 11 | 0.140 |
Why?
|
| Stillbirth | 1 | 2017 | 12 | 0.140 |
Why?
|
| Solvents | 1 | 2017 | 90 | 0.140 |
Why?
|
| Epistasis, Genetic | 1 | 2018 | 90 | 0.140 |
Why?
|
| Naltrexone | 1 | 2019 | 139 | 0.140 |
Why?
|
| Dietary Exposure | 1 | 2017 | 2 | 0.140 |
Why?
|
| Chromosomes, Human | 1 | 2017 | 65 | 0.140 |
Why?
|
| DNA Helicases | 1 | 2017 | 85 | 0.140 |
Why?
|
| Narcotic Antagonists | 1 | 2019 | 165 | 0.140 |
Why?
|
| Surveys and Questionnaires | 3 | 2022 | 2729 | 0.130 |
Why?
|
| Abortion, Spontaneous | 1 | 2017 | 67 | 0.130 |
Why?
|
| Mutation | 2 | 2024 | 4212 | 0.130 |
Why?
|
| Drinking | 3 | 2011 | 34 | 0.130 |
Why?
|
| Creatinine | 1 | 2017 | 296 | 0.130 |
Why?
|
| Depressive Disorder | 1 | 2017 | 224 | 0.130 |
Why?
|
| Age Factors | 2 | 2018 | 1903 | 0.130 |
Why?
|
| Health Surveys | 3 | 2023 | 242 | 0.130 |
Why?
|
| DNA Copy Number Variations | 1 | 2017 | 184 | 0.130 |
Why?
|
| Parents | 1 | 2018 | 296 | 0.120 |
Why?
|
| Areca | 2 | 2013 | 10 | 0.120 |
Why?
|
| Follow-Up Studies | 4 | 2018 | 3777 | 0.120 |
Why?
|
| Heart Diseases | 2 | 2016 | 308 | 0.120 |
Why?
|
| Lead | 1 | 2015 | 28 | 0.120 |
Why?
|
| Precision Medicine | 1 | 2019 | 425 | 0.120 |
Why?
|
| Dyspnea | 1 | 2016 | 80 | 0.120 |
Why?
|
| Proteinuria | 1 | 2015 | 69 | 0.120 |
Why?
|
| Anxiety Disorders | 1 | 2016 | 156 | 0.120 |
Why?
|
| Fetal Blood | 1 | 2015 | 93 | 0.120 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 2013 | 1939 | 0.110 |
Why?
|
| Mitochondria | 1 | 2018 | 597 | 0.110 |
Why?
|
| Developing Countries | 1 | 2015 | 83 | 0.110 |
Why?
|
| Illinois | 1 | 2016 | 502 | 0.110 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2015 | 102 | 0.110 |
Why?
|
| Germ-Line Mutation | 1 | 2017 | 358 | 0.110 |
Why?
|
| Phosphofructokinase-1, Muscle Type | 1 | 2014 | 9 | 0.110 |
Why?
|
| Chondromatosis | 1 | 1993 | 2 | 0.110 |
Why?
|
| Leiomyoma, Epithelioid | 1 | 1993 | 2 | 0.110 |
Why?
|
| Paraganglioma, Extra-Adrenal | 1 | 1993 | 11 | 0.110 |
Why?
|
| Anxiety | 1 | 2016 | 324 | 0.110 |
Why?
|
| Mediastinal Neoplasms | 1 | 1993 | 45 | 0.110 |
Why?
|
| Arm | 1 | 2014 | 96 | 0.110 |
Why?
|
| Depression | 1 | 2017 | 526 | 0.110 |
Why?
|
| Atrial Fibrillation | 1 | 2018 | 377 | 0.100 |
Why?
|
| Texas | 2 | 2024 | 126 | 0.100 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 1993 | 107 | 0.100 |
Why?
|
| Overweight | 1 | 2014 | 120 | 0.100 |
Why?
|
| Multifactorial Inheritance | 1 | 2015 | 188 | 0.100 |
Why?
|
| Vitamin E | 2 | 2014 | 32 | 0.100 |
Why?
|
| Urinary Bladder | 1 | 2015 | 250 | 0.100 |
Why?
|
| Keratosis | 1 | 2012 | 21 | 0.100 |
Why?
|
| Models, Statistical | 1 | 2016 | 578 | 0.100 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2015 | 462 | 0.100 |
Why?
|
| Gene Regulatory Networks | 1 | 2014 | 315 | 0.100 |
Why?
|
| Chromosomes, Human, Pair 10 | 1 | 2012 | 47 | 0.090 |
Why?
|
| Alleles | 4 | 2019 | 1142 | 0.090 |
Why?
|
| Double-Blind Method | 2 | 2013 | 1756 | 0.090 |
Why?
|
| Tremor | 1 | 2011 | 23 | 0.090 |
Why?
|
| Essential Tremor | 1 | 2011 | 6 | 0.090 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2015 | 374 | 0.090 |
Why?
|
| Methylation | 3 | 2019 | 280 | 0.090 |
Why?
|
| Skin | 1 | 2014 | 594 | 0.090 |
Why?
|
| Tissue Fixation | 1 | 2010 | 40 | 0.090 |
Why?
|
| Formaldehyde | 1 | 2010 | 51 | 0.090 |
Why?
|
| Paraffin Embedding | 1 | 2010 | 78 | 0.090 |
Why?
|
| Stomach Neoplasms | 1 | 1993 | 297 | 0.090 |
Why?
|
| Thyroid Hormones | 2 | 2023 | 349 | 0.080 |
Why?
|
| Protective Agents | 1 | 2010 | 34 | 0.080 |
Why?
|
| MicroRNAs | 1 | 2015 | 575 | 0.080 |
Why?
|
| Health Knowledge, Attitudes, Practice | 2 | 2022 | 542 | 0.080 |
Why?
|
| Population Surveillance | 1 | 2011 | 214 | 0.080 |
Why?
|
| Water | 1 | 2011 | 292 | 0.080 |
Why?
|
| DNA | 1 | 2014 | 1314 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 18 | 1 | 2008 | 42 | 0.070 |
Why?
|
| Chromosomes, Human, Pair 16 | 1 | 2008 | 79 | 0.070 |
Why?
|
| Chromosomes, Human, Pair 2 | 1 | 2008 | 85 | 0.070 |
Why?
|
| Protein Carbonylation | 1 | 2008 | 10 | 0.070 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2008 | 101 | 0.070 |
Why?
|
| Gene Dosage | 1 | 2008 | 212 | 0.070 |
Why?
|
| Gene Frequency | 2 | 2019 | 696 | 0.070 |
Why?
|
| Rural Population | 3 | 2014 | 151 | 0.070 |
Why?
|
| Sex Characteristics | 2 | 2019 | 331 | 0.070 |
Why?
|
| Ownership | 1 | 2007 | 27 | 0.070 |
Why?
|
| Chronic Disease | 1 | 2010 | 966 | 0.070 |
Why?
|
| Population Groups | 1 | 2006 | 41 | 0.060 |
Why?
|
| Cause of Death | 3 | 2013 | 270 | 0.060 |
Why?
|
| Risk Assessment | 3 | 2018 | 2368 | 0.060 |
Why?
|
| Chromosome Mapping | 1 | 2008 | 1078 | 0.060 |
Why?
|
| Computer Simulation | 2 | 2022 | 1112 | 0.060 |
Why?
|
| Emigrants and Immigrants | 1 | 2025 | 44 | 0.060 |
Why?
|
| Carcinoma, Basal Cell | 1 | 2024 | 62 | 0.050 |
Why?
|
| Vegetables | 2 | 2015 | 47 | 0.050 |
Why?
|
| Demography | 2 | 2015 | 186 | 0.050 |
Why?
|
| Postmenopause | 1 | 2023 | 102 | 0.050 |
Why?
|
| Particulate Matter | 1 | 2023 | 104 | 0.050 |
Why?
|
| Age of Onset | 2 | 2017 | 332 | 0.050 |
Why?
|
| Sleep Apnea Syndromes | 1 | 2023 | 107 | 0.050 |
Why?
|
| Income | 1 | 2022 | 87 | 0.050 |
Why?
|
| Research Design | 1 | 2006 | 600 | 0.050 |
Why?
|
| Insulins | 1 | 2022 | 7 | 0.050 |
Why?
|
| Animals | 2 | 2019 | 28053 | 0.050 |
Why?
|
| Lung Neoplasms | 1 | 1993 | 2395 | 0.040 |
Why?
|
| Thyrotropin | 1 | 2022 | 302 | 0.040 |
Why?
|
| Accelerometry | 1 | 2021 | 44 | 0.040 |
Why?
|
| Triiodothyronine | 1 | 2022 | 359 | 0.040 |
Why?
|
| Michigan | 1 | 2020 | 53 | 0.040 |
Why?
|
| Thyroxine | 1 | 2022 | 376 | 0.040 |
Why?
|
| Waist-Hip Ratio | 1 | 2018 | 20 | 0.040 |
Why?
|
| Folic Acid | 1 | 2019 | 64 | 0.040 |
Why?
|
| Electronic Health Records | 1 | 2022 | 364 | 0.040 |
Why?
|
| Linkage Disequilibrium | 1 | 2019 | 478 | 0.040 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2019 | 141 | 0.040 |
Why?
|
| Health Education | 1 | 2019 | 105 | 0.040 |
Why?
|
| Estrogens | 1 | 2019 | 200 | 0.040 |
Why?
|
| Machine Learning | 1 | 2021 | 298 | 0.040 |
Why?
|
| Obesity, Abdominal | 1 | 2017 | 8 | 0.040 |
Why?
|
| Glutathione Transferase | 1 | 2018 | 112 | 0.040 |
Why?
|
| Breast | 1 | 2019 | 289 | 0.030 |
Why?
|
| Lipoproteins, LDL | 1 | 2017 | 86 | 0.030 |
Why?
|
| Adipocytes | 1 | 2018 | 170 | 0.030 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2024 | 1091 | 0.030 |
Why?
|
| Mutation, Missense | 1 | 2019 | 288 | 0.030 |
Why?
|
| Adiposity | 1 | 2017 | 77 | 0.030 |
Why?
|
| RNA, Small Interfering | 1 | 2019 | 562 | 0.030 |
Why?
|
| Longevity | 1 | 2017 | 58 | 0.030 |
Why?
|
| Triglycerides | 1 | 2017 | 234 | 0.030 |
Why?
|
| Receptors, Progesterone | 1 | 2018 | 179 | 0.030 |
Why?
|
| Genetics, Population | 1 | 2019 | 418 | 0.030 |
Why?
|
| Dyslipidemias | 1 | 2017 | 107 | 0.030 |
Why?
|
| Time Factors | 2 | 2015 | 5429 | 0.030 |
Why?
|
| Computational Biology | 1 | 2019 | 568 | 0.030 |
Why?
|
| Receptors, Estrogen | 1 | 2018 | 401 | 0.030 |
Why?
|
| Self Report | 1 | 2017 | 307 | 0.030 |
Why?
|
| Retrospective Studies | 3 | 2024 | 9689 | 0.030 |
Why?
|
| Glucose | 1 | 2018 | 683 | 0.030 |
Why?
|
| Sex Hormone-Binding Globulin | 1 | 2015 | 20 | 0.030 |
Why?
|
| Fruit | 1 | 2015 | 78 | 0.030 |
Why?
|
| Asia | 1 | 2014 | 102 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 1 | 2018 | 972 | 0.030 |
Why?
|
| Immunoenzyme Techniques | 1 | 2015 | 299 | 0.030 |
Why?
|
| Data Collection | 2 | 2006 | 379 | 0.030 |
Why?
|
| Chemoprevention | 1 | 2014 | 93 | 0.030 |
Why?
|
| Comorbidity | 1 | 2018 | 986 | 0.030 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2015 | 143 | 0.030 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2015 | 289 | 0.030 |
Why?
|
| Insulin | 1 | 2018 | 1166 | 0.030 |
Why?
|
| Poverty | 1 | 2015 | 189 | 0.030 |
Why?
|
| Causality | 1 | 2013 | 81 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2017 | 1511 | 0.030 |
Why?
|
| Data Interpretation, Statistical | 1 | 2015 | 306 | 0.030 |
Why?
|
| Disease Progression | 1 | 2018 | 1505 | 0.030 |
Why?
|
| Spectrophotometry, Atomic | 1 | 2013 | 12 | 0.030 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2016 | 864 | 0.030 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2015 | 210 | 0.030 |
Why?
|
| Respiratory Function Tests | 1 | 2013 | 145 | 0.030 |
Why?
|
| Blotting, Western | 1 | 2015 | 794 | 0.030 |
Why?
|
| Organ Size | 1 | 2014 | 374 | 0.030 |
Why?
|
| Inflammation | 1 | 2019 | 1024 | 0.030 |
Why?
|
| Neoplasm Invasiveness | 1 | 2015 | 569 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2015 | 888 | 0.030 |
Why?
|
| Syndrome | 1 | 1993 | 449 | 0.030 |
Why?
|
| Mass Spectrometry | 1 | 2013 | 198 | 0.020 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2013 | 309 | 0.020 |
Why?
|
| Tobacco, Smokeless | 1 | 2011 | 10 | 0.020 |
Why?
|
| Genomics | 1 | 2018 | 807 | 0.020 |
Why?
|
| Polymorphism, Genetic | 1 | 2015 | 827 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2019 | 3375 | 0.020 |
Why?
|
| Diabetes Mellitus | 1 | 2018 | 760 | 0.020 |
Why?
|
| Food Analysis | 1 | 2011 | 4 | 0.020 |
Why?
|
| Community Health Planning | 1 | 2011 | 22 | 0.020 |
Why?
|
| Cucurbitaceae | 1 | 2010 | 4 | 0.020 |
Why?
|
| Cell Movement | 1 | 2015 | 801 | 0.020 |
Why?
|
| Fertilizers | 1 | 2010 | 9 | 0.020 |
Why?
|
| Mastication | 1 | 2011 | 78 | 0.020 |
Why?
|
| Genes, Neoplasm | 1 | 2010 | 38 | 0.020 |
Why?
|
| Sunlight | 1 | 2010 | 28 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2011 | 305 | 0.020 |
Why?
|
| Interviews as Topic | 1 | 2011 | 351 | 0.020 |
Why?
|
| Prognosis | 1 | 2018 | 3872 | 0.020 |
Why?
|
| Epidemiologic Methods | 1 | 2010 | 59 | 0.020 |
Why?
|
| Epidemiological Monitoring | 1 | 2010 | 40 | 0.020 |
Why?
|
| Principal Component Analysis | 1 | 2010 | 164 | 0.020 |
Why?
|
| Organ Specificity | 1 | 2010 | 283 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2010 | 376 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2015 | 2905 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2010 | 524 | 0.020 |
Why?
|
| Respiratory Tract Diseases | 1 | 2009 | 45 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2015 | 2038 | 0.020 |
Why?
|
| Intelligence | 1 | 2009 | 71 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2010 | 899 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2015 | 1724 | 0.020 |
Why?
|
| Apoptosis | 1 | 2015 | 1745 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2019 | 3509 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2010 | 729 | 0.020 |
Why?
|
| Nervous System Diseases | 1 | 2009 | 159 | 0.020 |
Why?
|
| Appendicitis | 1 | 1988 | 65 | 0.020 |
Why?
|
| Dietary Supplements | 1 | 2008 | 126 | 0.020 |
Why?
|
| Oxidation-Reduction | 1 | 2008 | 402 | 0.020 |
Why?
|
| Haplotypes | 1 | 2008 | 639 | 0.020 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2007 | 206 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2019 | 8730 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2008 | 806 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2008 | 902 | 0.010 |
Why?
|
| Proteins | 1 | 2010 | 803 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2011 | 1920 | 0.010 |
Why?
|
| Mice | 1 | 2019 | 12136 | 0.010 |
Why?
|
| Risk | 1 | 2006 | 661 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2010 | 2793 | 0.010 |
Why?
|
| RNA | 1 | 2007 | 589 | 0.010 |
Why?
|
| False Negative Reactions | 1 | 1988 | 63 | 0.000 |
Why?
|
| False Positive Reactions | 1 | 1988 | 220 | 0.000 |
Why?
|
| Acute Disease | 1 | 1988 | 855 | 0.000 |
Why?
|
| Ultrasonography | 1 | 1988 | 707 | 0.000 |
Why?
|